Related Experiment Video
Updated: Aug 10, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Abstract:
Clinical trials of the antiviral action of interferon have shown an effect on the replication of several viruses including varicella zoster, herpes simplex, cytomegalovirus and hepatitis B. These studies indicate that administration early in the course of infection, or in some clinical circumstances, prophylactic administration, is likely to result in viral inhibition. The studies of interferon efficacy in topical application, as in prevention of recurrent herpes simplex keratitis, have shown limited efficacy except with very high doses. These studies are being pursued with more concentrated preparations of interferon. The evaluation of interferon in human malignancy is just beginning, but some encouraging results have been obtained in open trials of the drug in patients with non-Hodgkin's lymphoma, melanoma, osteogenic sarcoma, and other diseases. With newer methods for the production of interferon, it may be possible to evaluate its antiviral and anti-tumor effects in carefully controlled studies with larger numbers of subjects.
Insights
Interferon shows antiviral effects against viruses like herpes and hepatitis B, and early trials suggest anti-tumor potential in cancers such as lymphoma and melanoma. Further research with concentrated preparations and larger studies is ongoing.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Interferon demonstrates antiviral properties against various viruses, including herpes simplex virus and hepatitis B.
- Topical interferon application has shown limited efficacy for herpes simplex keratitis, necessitating higher doses or concentrated preparations.
Purpose of the Study:
- To review the antiviral and early anti-tumor effects of interferon.
- To discuss the potential of interferon in treating viral infections and human malignancies.
Main Methods:
- Clinical trials evaluating interferon's efficacy in viral infections.
- Open trials assessing interferon's impact on various human cancers.
Main Results:
- Interferon effectively inhibits viral replication when administered early or prophylactically.
- Encouraging preliminary results observed in interferon treatment for non-Hodgkin's lymphoma, melanoma, and osteogenic sarcoma.
Conclusions:
- Interferon holds promise as an antiviral agent, particularly with early or prophylactic administration.
- Emerging evidence suggests interferon may have therapeutic potential in treating certain human malignancies.
- Advancements in interferon production will facilitate larger, controlled studies to further evaluate its clinical applications.
More Related Videos
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Tumor Immunotherapy
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

